KD-416

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug NameKD-416
Drug Alias NameBlood coagulation factor X agent (Meiji Seika Pharmatech Co Ltd)KD-416KD416
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X replacement
TargetsCoagulation factor X
Therapy Area/IndicationsFactor X Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsFactor X Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A